Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Fast calcium transients in dendritic spines driven by extreme statistics.

Basnayake K, Mazaud D, Bemelmans A, Rouach N, Korkotian E, Holcman D.

PLoS Biol. 2019 Jun 4;17(6):e2006202. doi: 10.1371/journal.pbio.2006202. eCollection 2019 Jun.

2.

Fastest among equals: a novel paradigm in biology: Reply to comments: Redundancy principle and the role of extreme statistics in molecular and cellular biology.

Basnayake K, Holcman D.

Phys Life Rev. 2019 Mar;28:96-99. doi: 10.1016/j.plrev.2019.03.017. Epub 2019 May 22. No abstract available.

PMID:
31151792
3.

Secretion of IL-1β From Monocytes in Gout Is Redox Independent.

Alberts BM, Bruce C, Basnayake K, Ghezzi P, Davies KA, Mullen LM.

Front Immunol. 2019 Jan 29;10:70. doi: 10.3389/fimmu.2019.00070. eCollection 2019.

4.

Redundancy principle and the role of extreme statistics in molecular and cellular biology.

Schuss Z, Basnayake K, Holcman D.

Phys Life Rev. 2019 Mar;28:52-79. doi: 10.1016/j.plrev.2019.01.001. Epub 2019 Jan 11. Review.

PMID:
30691960
5.

A haemocompatible and scalable nanoporous adsorbent monolith synthesised using a novel lignin binder route to augment the adsorption of poorly removed uraemic toxins in haemodialysis.

Sandeman SR, Zheng Y, Ingavle GC, Howell CA, Mikhalovsky SV, Basnayake K, Boyd O, Davenport A, Beaton N, Davies N.

Biomed Mater. 2017 May 10;12(3):035001. doi: 10.1088/1748-605X/aa6546.

PMID:
28270638
6.

Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injury.

Yadav P, Hutchison CA, Basnayake K, Stringer S, Jesky M, Fifer L, Snell K, Pinney J, Drayson MT, Cook M, Cockwell P.

Eur J Haematol. 2016 Jun;96(6):610-7. doi: 10.1111/ejh.12644. Epub 2015 Sep 16.

PMID:
26248588
7.

The importance of screening for serum free light chains in suspected cases of multiple myeloma and their impact on the kidney.

Talbot B, Wright D, Basnayake K.

BMJ Case Rep. 2014 Oct 17;2014. pii: bcr2014206688. doi: 10.1136/bcr-2014-206688.

8.

Serum polyclonal immunoglobulin free light chain levels predict mortality in people with chronic kidney disease.

Hutchison CA, Burmeister A, Harding SJ, Basnayake K, Church H, Jesky MD, White K, Green CE, Stringer SJ, Bassett P, Ferro CJ, Cockwell P.

Mayo Clin Proc. 2014 May;89(5):615-22. doi: 10.1016/j.mayocp.2014.01.028.

9.

An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis.

Sandeman SR, Howell CA, Phillips GJ, Zheng Y, Standen G, Pletzenauer R, Davenport A, Basnayake K, Boyd O, Holt S, Mikhalovsky SV.

J Mater Sci Mater Med. 2014 Jun;25(6):1589-97. doi: 10.1007/s10856-014-5173-9. Epub 2014 Feb 27.

10.

Recent advances in the pathogenesis and management of cast nephropathy (myeloma kidney).

Stringer S, Basnayake K, Hutchison C, Cockwell P.

Bone Marrow Res. 2011;2011:493697. doi: 10.1155/2011/493697. Epub 2011 May 4.

11.

The biology of immunoglobulin free light chains and kidney injury.

Basnayake K, Stringer SJ, Hutchison CA, Cockwell P.

Kidney Int. 2011 Jun;79(12):1289-301. doi: 10.1038/ki.2011.94. Epub 2011 Apr 13. Review.

12.

Immunoglobulin light chains activate nuclear factor-κB in renal epithelial cells through a Src-dependent mechanism.

Ying WZ, Wang PX, Aaron KJ, Basnayake K, Sanders PW.

Blood. 2011 Jan 27;117(4):1301-7. doi: 10.1182/blood-2010-08-302505. Epub 2010 Nov 22.

13.

Differential progression of renal scarring and determinants of late renal recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney.

Basnayake K, Cheung CK, Sheaff M, Fuggle W, Kamel D, Nakoinz S, Hutchison CA, Cook M, Stoves J, Bradwell AR, Cockwell P.

J Clin Pathol. 2010 Oct;63(10):884-7. doi: 10.1136/jcp.2010.079236.

PMID:
20876319
14.

Immunoglobulin light chains activate tubular epithelial cells through redox signaling.

Basnayake K, Ying WZ, Wang PX, Sanders PW.

J Am Soc Nephrol. 2010 Jul;21(7):1165-73. doi: 10.1681/ASN.2009101089. Epub 2010 Jun 17.

15.

Rhabdomyolysis and acute kidney injury.

Basnayake K, Cockwell P, Hutchison CA.

N Engl J Med. 2009 Oct 1;361(14):1411-2; author reply 1412-3. doi: 10.1056/NEJMc091538. No abstract available.

PMID:
19797292
16.

Serum free light chain assessment in monoclonal gammopathy and kidney disease.

Hutchison CA, Basnayake K, Cockwell P.

Nat Rev Nephrol. 2009 Nov;5(11):621-8. doi: 10.1038/nrneph.2009.151. Epub 2009 Sep 29. Review.

PMID:
19786994
17.

Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis.

Hutchison CA, Bradwell AR, Cook M, Basnayake K, Basu S, Harding S, Hattersley J, Evans ND, Chappel MJ, Sampson P, Foggensteiner L, Adu D, Cockwell P.

Clin J Am Soc Nephrol. 2009 Apr;4(4):745-54. doi: 10.2215/CJN.04590908. Epub 2009 Apr 1.

18.

Resolution of cast nephropathy following free light chain removal by haemodialysis in a patient with multiple myeloma: a case report.

Basnayake K, Hutchison C, Kamel D, Sheaff M, Ashman N, Cook M, Oakervee H, Bradwell A, Cockwell P.

J Med Case Rep. 2008 Dec 9;2:380. doi: 10.1186/1752-1947-2-380.

19.

Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.

Hutchison CA, Plant T, Drayson M, Cockwell P, Kountouri M, Basnayake K, Harding S, Bradwell AR, Mead G.

BMC Nephrol. 2008 Sep 22;9:11. doi: 10.1186/1471-2369-9-11.

Supplemental Content

Loading ...
Support Center